Outset Medical Operating Income 2019-2025 | OM

Outset Medical operating income from 2019 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Outset Medical Annual Operating Income
(Millions of US $)
2024 $-113
2023 $-170
2022 $-161
2021 $-131
2020 $-117
2019 $-70
2018 $-47
Outset Medical Quarterly Operating Income
(Millions of US $)
2025-03-31 $-16
2024-12-31 $-22
2024-09-30 $-24
2024-06-30 $-31
2024-03-31 $-37
2023-12-31 $-37
2023-09-30 $-45
2023-06-30 $-43
2023-03-31 $-43
2022-12-31 $-40
2022-09-30 $-41
2022-06-30 $-44
2022-03-31 $-36
2021-12-31 $-41
2021-09-30 $-30
2021-06-30 $-30
2021-03-31 $-30
2020-12-31 $-32
2020-09-30 $-41
2020-06-30 $-25
2020-03-31 $-20
2019-12-31
2019-09-30 $-18
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.316B $0.114B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.332B 57.93
Hims & Hers Health (HIMS) United States $12.707B 132.02
Tempus AI (TEM) United States $10.988B 0.00
IRhythm Technologies (IRTC) United States $4.490B 0.00
Inspire Medical Systems (INSP) United States $3.944B 61.63
Hinge Health (HNGE) United States $3.156B 0.00
Privia Health (PRVA) United States $2.783B 190.25
Enovis (ENOV) United States $1.694B 9.44
Clover Health Investments (CLOV) United States $1.613B 0.00
Schrodinger (SDGR) United States $1.592B 0.00
Phreesia (PHR) United States $1.482B 0.00
Omnicell (OMCL) United States $1.415B 24.96
Azenta (AZTA) United States $1.219B 56.66
10x Genomics (TXG) United States $1.164B 0.00
Fulgent Genetics (FLGT) United States $0.629B 0.00
Claritev (CTEV) United States $0.629B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.561B 167.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.357B 791.67
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.194B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
American Well (AMWL) United States $0.103B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
P3 Health Partners (PIII) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00